Aspect Biosystems raises US$115 million in Series B funding to advance multiple bioprinted tissue therapeutics towards the ...
At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback